Home › Funds › EMERALD ADVISERS, LLC › TMDX

EMERALD ADVISERS, LLC position in TMDX

TRANSMEDICS GROUP INC · Health Care

EMERALD ADVISERS, LLC reported holding 493,026 shares of TMDX (TRANSMEDICS GROUP INC) in its Q3 2026 13F filing — a position valued at US$41.1M, representing 1.13% of its reported portfolio and ranking #28 among its reported holdings. EMERALD ADVISERS, LLC has disclosed TMDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)493.03K sh
Reported value held$41.14M
Portfolio Weight1.13%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EMERALD ADVISERS, LLC's TMDX position evolved

EMERALD ADVISERS, LLC first disclosed a stake in TMDX in Q3 2023 at 442,546 shares (US$24.2M). The position peaked in Q2 2025 at 439,329 shares, worth US$58.9M. Across 13 filings, EMERALD ADVISERS, LLC increased the stake 6 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 493,026 shares valued at US$41.1M — an increase of 2,535 shares quarter over quarter.. Notable position changes include a 53% trim in Q3 2024 (shares fell 60% over the following quarter), a 146% increase in Q4 2024 (shares rose 8% over the following quarter), a 43% increase in Q2 2026 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 442.55K $24.23M New
Q4 2023 516.35K $40.76M Add
Q1 2024 523.42K $38.70M Add
Q2 2024 323.35K $48.70M Reduce
Q3 2024 150.91K $23.69M Reduce
Q4 2024 371.71K $23.18M Add
Q1 2025 454.79K $30.60M Add
Q2 2025 439.33K $58.87M Reduce
Q3 2025 387.59K $43.49M Reduce
Q4 2025 351.35K $42.74M Reduce
Q1 2026 342.79K $34.08M Reduce
Q2 2026 490.49K $32.58M Add
Q3 2026 493.03K $41.14M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TMDX and 13F data

TMDX (TRANSMEDICS GROUP INC) is a Health Care company. 22 other funds we track also report a position in TMDX — the largest reported positions include TENOR CAPITAL MANAGEMENT Co., L.P. (US$64.8M), DeepCurrents Investment Group LLC (US$58.8M), BRAIDWELL LP (US$40.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TMDX

All TMDX fund holders →

FAQ

How long has EMERALD ADVISERS, LLC held TMDX?

EMERALD ADVISERS, LLC has disclosed TMDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EMERALD ADVISERS, LLC's current position in TMDX?

As of Q3 2026, EMERALD ADVISERS, LLC holds 493.03K shares of TMDX (TRANSMEDICS GROUP INC), valued at $41.14M, representing 1.13% of its reported portfolio and ranking #28.

Has EMERALD ADVISERS, LLC been buying or selling TMDX?

In the latest 13F filing (Q3 2026), EMERALD ADVISERS, LLC increased its position in TMDX. The position peaked in Q2 2025 at 439.33K shares.

Which other funds hold TMDX?

Other major institutional holders of TMDX include TENOR CAPITAL MANAGEMENT Co., L.P., DeepCurrents Investment Group LLC, BRAIDWELL LP, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.